CCWM
TRAW icon

Cassaday & Co Wealth Management’s Traws Pharma TRAW Stock Holding History

Cassaday & Co Wealth Management’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21 Buy
+11
New +$21 ﹤0.01% 1355

Other funds holding TRAW

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $410M AUM 32.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Cassaday & Co Wealth Management's TRAW Position: Q1 2026 in Review

Cassaday & Co Wealth Management opened a new position in Traws Pharma (TRAW) in Q1 2026: 11 shares worth $21. The stake represents ﹤0.01% of the portfolio and ranks #1355 among its holdings.

28 funds tracked by Wall St. Rank hold TRAW as of Q1 2026.

  • Cassaday & Co Wealth Management held 11 shares of Traws Pharma worth $21 as of Q1 2026.
  • Traws Pharma was a new Cassaday & Co Wealth Management position in Q1 2026.
  • Traws Pharma made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q1 2026, its #1355 holding.
  • 28 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.